Full-Time

Strategic Account Manager

Labviva

Labviva

51-200 employees

AI-powered procurement platform for life sciences

Compensation Overview

$140k - $165k/yr

+ Equity

Boston, MA, USA

Hybrid

3 days in-office per week (Tue–Thu); must reside in the greater Boston area.

Category
Sales & Account Management (1)
Required Skills
Inventory Management
JIRA
Confluence
Oracle
Data Analysis
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Bachelor’s degree
  • at least 5+ years in working in Pharma and Biotech Procurement & Purchasing
  • Experience working with, or for, enterprise customers in Biotech, Life Sciences, or higher-education research institutions
  • Experience with lab consumables inventory management (preferred)
  • Minimum 2 years’ experience integrating or selling software and/or hands-on usage of e-Procurement platforms such as Ariba, Oracle, and Jaggaer
  • Ability to travel up to 20% to customer sites both domestically and internationally, including travel to corporate headquarters in Boston
  • Naturally organized and detail-oriented, with the ability to drive projects that rely on multiple cross-functional teams
  • Comfortable communicating with senior executives externally, and the ability to work with all internal teams both technical and non-technical to execute customer goals
  • Independent worker who is comfortable navigating a growing startup organization in a fast-paced environment
  • Ability to prioritize and pivot, with strong problem-solving
  • Outstanding multi-task management skills across a varied set of responsibilities
  • Expertise in Microsoft Suite, strong PowerPoint and Excel skills, JIRA, Confluence, and Data Analysis
  • Strong written, verbal, and presentation communication skills

Labviva provides an AI-powered procurement platform for the life sciences sector. It runs a digital marketplace that connects researchers and procurement teams with a broad network of suppliers while integrating with enterprise systems like SAP Ariba, Oracle Procurement Cloud, and JAGGAER so organizations can keep existing contracts and pricing. AI powers advanced search and analyzes product attributes from scientific literature to help users compare products and find cost-saving options, and an automated inventory management system offers real-time stock visibility with AI forecasting and QR-based replenishment. The goal is to streamline life sciences purchasing, reduce costs, and improve lab operations by expanding access to suppliers and providing actionable analytics.

Company Size

51-200

Company Stage

Series B

Total Funding

$55M

Headquarters

Cambridge, Massachusetts

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • European expansion via London HQ targets $7B AI biopharmaceutical operations market opportunity.[1]
  • Supplier diversity compliance modules address mandatory procurement requirements for pharma and research institutions.[4]
  • AI-driven forecasting and real-time visibility address post-pandemic supply chain volatility concerns.[5]

What critics are saying

  • Thermo Fisher's AI procurement module with 40% market share threatens Labviva's 20% savings differentiation.[1]
  • SAP Ariba's native life sciences AI sourcing add-on renders Labviva's overlay integration obsolete.[2]
  • OpenAI-Sigma-Aldrich generative AI catalog search commoditizes Labviva's core AI differentiation by 2027.[3]

What makes Labviva unique

  • AI-native platform integrates with existing SAP, Oracle, Jaggaer systems without replacement.[7]
  • Connects researchers to 90% of life sciences suppliers including small and green-certified businesses.[4]
  • Harper Chemical automates chemical procurement workflows, addressing specialized life sciences pain points.[2]

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Labviva who can refer or advise you

Benefits

Health Insurance

Hybrid Work Options

Paid Vacation

Parental Leave

Company Equity

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

6%

2 year growth

1%
Perspective Publishing Limited
Apr 10th, 2026
TT Electronics announces new permanent CFO.

TT Electronics announces new permanent CFO. By Michael Griffiths 10/04/2026 TT Electronics has announced the appointment of Ian Ashton as the group's new chief financial officer (CFO). Ashton, who will also become an executive director at TT, is currently the CFO of SIG, a role he has had since 2020. Prior to joining SIG, Ashton served as CFO at Low & Bonar until its acquisition by the Freudenberg Group, and before that he was CFO of Labviva, a US-based technology company. He has also served in several senior financial roles at Smith & Nephew. Ashton will join TT following the completion of his current notice period of up to a maximum of six months. He will succeed Richard Webb in the role, who has been TT's interim CFO since May last year. Webb will continue on an interim basis until Ashton joins TT, and will support an orderly handover. "I'm delighted to have been appointed CFO of TT," Ashton said. "The group has a huge amount of potential, with strong market positions and a clear strategy in place, and I am excited at what lies ahead. I greatly look forward to working alongside Eric and the rest of the management team to help deliver further operational and financial progress." TT's CEO, Eric Lakin, added: "Corporate Finance News is delighted to announce Ian's appointment as CFO. He brings a strong combination of financial expertise, operational insight and leadership experience, which will support the group in building on the positive progress achieved over the past 12 months in creating a clearer strategic direction and a stronger platform for growth. "I would like to thank Richard for his support, and I look forward to working with him to ensure a smooth transition. Ian is an excellent fit for TT and I'm excited about working closely with him."

Genetic Engineering and Biotechnology News
Jun 27th, 2025
Labviva Automates Chemical Supply Chain for the Life Sciences Industry

Labviva announced the general availability of Harper Chemical (HarperChem), a new part of its cloud-based inventory management system (IMS).

PharmiWeb.com
May 15th, 2025
Labviva Announces Global Expansion, Appoints General Manager Of Europe

Leading life sciences technology company to accelerate adoption of automated procurement and supplier diversity worldwideBOSTON and LONDON , May 15, 2025 (GLOBE NEWSWIRE) -- Tariffs, trade barriers, and fragmented regulatory environments are disrupting the global supply chain and threatening the life sciences industry worldwide. That’s why Labviva, the leading AI procurement platform for life sciences, today announced its entry into Europe, establishing an international headquarters in London, and appointing life sciences veteran Dr. Carlo Iannicola as general manager. As part of the announcement, the company plans to accelerate global adoption of AI-enabled supply chain procurement while delivering a vast pool of diversified suppliers to Europe’s life sciences community.Resolving a Fragmented Global Life Sciences Supply ChainMcKinsey reports that pharmaceutical procurement is inefficient and time-consuming, citing manual entries consume up to 30% of staff time, while life sciences suppliers struggle to digitize and integrate key data sources. It also recently identified augmented sourcing and realtime inventory optimization as powerful use cases capable of driving mass efficiencies in the sector. With the potential to reduce procurement management costs by up to 10% and increase productivity by up to 80%, AI in biopharmaceutical operations is a $7 billion annual business.The “Amazonification” of Supply Chain ProcurementLabviva instantly connects research organizations with 90% of all life sciences manufacturers in the U.S

LifeCare News
Jan 13th, 2025
Labviva Secures $25M for Global Expansion

Labviva, an AI procurement platform for life sciences, secured $25 million in Series B funding, totaling $55 million. Led by 53 Stations, with participation from Biospring Partners, B Capital Group, and Glasswing Ventures, the funds will accelerate product development, marketing, and global expansion. Jason Pritzker from 53 Stations joins Labviva's Board. Labviva aims to enhance supply chain transparency and efficiency in life sciences, supporting major pharmaceutical companies and research institutions.

LifeCare News
Jan 13th, 2025
Labviva Secures $25M to Accelerate Product Development and Global Expansion

Labviva secures $25M to accelerate product development and global expansion.